300765 新诺威
午间休市 09-24 11:30:00
资讯
新帖
简况
新诺威涨7.07%,东吴证券一个月前给出“买入”评级
证券之星 · 09-18
新诺威涨7.07%,东吴证券一个月前给出“买入”评级
新诺威:公司目前没有GLP-1相关产品
证券日报网 · 09-16
新诺威:公司目前没有GLP-1相关产品
新诺威:公司始终重视投资者利益
证券日报网 · 09-16
新诺威:公司始终重视投资者利益
股市必读:新诺威(300765)9月5日董秘有最新回复
证券之星 · 09-07
股市必读:新诺威(300765)9月5日董秘有最新回复
新诺威:截至2025年8月29日股东总数为15,362户
证券之星 · 09-05
新诺威:截至2025年8月29日股东总数为15,362户
中证全指食品指数报5940.96点,前十大权重包含新诺威等
市场资讯 · 09-03
中证全指食品指数报5940.96点,前十大权重包含新诺威等
9月1日新诺威涨6.71%,中欧医疗健康混合A基金重仓该股
证券之星 · 09-01
9月1日新诺威涨6.71%,中欧医疗健康混合A基金重仓该股
8月29日新诺威涨7.30%,中欧医疗健康混合A基金重仓该股
证券之星 · 08-29
8月29日新诺威涨7.30%,中欧医疗健康混合A基金重仓该股
8月25日新诺威涨6.69%,中欧医疗健康混合A基金重仓该股
证券之星 · 08-25
8月25日新诺威涨6.69%,中欧医疗健康混合A基金重仓该股
新诺威:截至2025年8月20日股东总数为16,737户
证券之星 · 08-22
新诺威:截至2025年8月20日股东总数为16,737户
新诺威最新公告:控股子公司SYS6036注射液获得药物临床试验批准通知书
证券之星 · 08-22
新诺威最新公告:控股子公司SYS6036注射液获得药物临床试验批准通知书
新诺威获融资买入0.21亿元,近三日累计买入0.61亿元
金融界 · 08-21
新诺威获融资买入0.21亿元,近三日累计买入0.61亿元
新诺威:度普利尤单抗注射液获得药物临床试验批准通知书
格隆汇 · 08-19
新诺威:度普利尤单抗注射液获得药物临床试验批准通知书
新诺威:控股子公司度普利尤单抗注射液获药物临床试验批准通知书
金融界 · 08-19
新诺威:控股子公司度普利尤单抗注射液获药物临床试验批准通知书
研报掘金丨东吴证券:维持新诺威“买入”评级,功能性食品和原料药业务逐步企稳
格隆汇 · 08-18
研报掘金丨东吴证券:维持新诺威“买入”评级,功能性食品和原料药业务逐步企稳
新诺威:截至2025年8月8日股东总数为15,619户
证券之星 · 08-15
新诺威:截至2025年8月8日股东总数为15,619户
新诺威最新公告:上半年净亏损274.61万元 同比盈转亏
证券之星 · 08-15
新诺威最新公告:上半年净亏损274.61万元 同比盈转亏
新诺威:上半年净亏损274.61万元
格隆汇 · 08-15
新诺威:上半年净亏损274.61万元
原料药上市公司财务总监PK:40岁及以下CFO占比26% 新诺威戴龙为业内最年轻CFO
新浪证券 · 08-08
原料药上市公司财务总监PK:40岁及以下CFO占比26% 新诺威戴龙为业内最年轻CFO
大行评级|里昂:中国医疗健康行业流动性及基本面持续改善,偏好领先大型药厂
格隆汇 · 08-05
大行评级|里昂:中国医疗健康行业流动性及基本面持续改善,偏好领先大型药厂
加载更多
公司概况
公司名称:
石药创新制药股份有限公司
所属行业:
食品制造业
上市日期:
2019-03-22
主营业务:
石药创新制药股份有限公司的主营业务是生物制药和功能食品及原料的研发、生产和销售。公司的主要产品是ADC、mRNA疫苗以及抗体类药物、咖啡因、维生素C含片。
发行价格:
24.47
{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"新诺威","latestPrice":51.73,"timestamp":1758687405000,"preClose":49.93,"halted":0,"volume":5596038,"delay":0,"changeRate":0.0361,"floatShares":1247000000,"shares":1405000000,"eps":-0.0613,"marketStatus":"午间休市","change":1.8,"latestTime":"09-24 11:30:00","open":49.9,"high":52.3,"low":49.51,"amount":287000000,"amplitude":0.0559,"askPrice":51.81,"askSize":43,"bidPrice":51.73,"bidSize":30,"shortable":0,"etf":0,"ttmEps":-0.0613,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758690000000},"marketStatusCode":3,"adr":0,"adjPreClose":49.93,"symbolType":"stock","openAndCloseTimeList":[[1758677400000,1758684600000],[1758690000000,1758697200000]],"highLimit":54.92,"lowLimit":44.94,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1404592944,"isCdr":false,"pbRate":18.92,"roa":"--","roe":"--","epsLYR":0.0384,"committee":0.312775,"marketValue":72660000000,"turnoverRate":0.0045,"status":0,"floatMarketCap":64511000000},"requestUrl":"/m/hq/s/300765","defaultTab":"news","newsList":[{"id":"2568427310","title":"新诺威涨7.07%,东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2568427310","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568427310?lang=zh_cn&edition=full","pubTime":"2025-09-18 16:36","pubTimestamp":1758184572,"startTime":"0","endTime":"0","summary":"今日新诺威(300765)涨7.07%,收盘报51.8元。2025年8月17日,东吴证券研究员朱国广发布了对新诺威的研报《2025年 中 报 点 评:持 续 加 码 研 发,EGFRADC下半年有望启动首个海外注册临床》,该研报对新诺威给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为79.59%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为东吴证券的朱国广。新诺威(300765)个股概况:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800025307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300765"],"gpt_icon":0},{"id":"2567107706","title":"新诺威:公司目前没有GLP-1相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107706","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567107706?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:39","pubTimestamp":1758022740,"startTime":"0","endTime":"0","summary":"证券日报网讯新诺威9月16日发布公告,在公司回答调研者提问时表示,公司目前没有GLP-1相关产品。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-16/doc-infqsxmi5719177.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-16/doc-infqsxmi5719177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","BK4590","GLP","300765","BK0226"],"gpt_icon":0},{"id":"2567107037","title":"新诺威:公司始终重视投资者利益","url":"https://stock-news.laohu8.com/highlight/detail?id=2567107037","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567107037?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:39","pubTimestamp":1758022740,"startTime":"0","endTime":"0","summary":"证券日报网讯新诺威9月16日发布公告,在公司回答调研者提问时表示,公司始终重视投资者利益,持续提升公司价值及市场认可度,努力为投资者创造更高的价值。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-16/doc-infqsxmc3546624.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-16/doc-infqsxmc3546624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2565552453","title":"股市必读:新诺威(300765)9月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2565552453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565552453?lang=zh_cn&edition=full","pubTime":"2025-09-08 02:31","pubTimestamp":1757269871,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,新诺威报收于57.2元,上涨2.93%,换手率0.66%,成交量8.17万手,成交额4.52亿元。董秘最新回复投资者: 请问,截至2025年八月 29日公司的股东总数是多少?谢谢董秘: 您好,感谢您对公司的关注,截至2025年8月29日,公司合并普通账户和融资融券信用账户股东数为15,362户,谢谢!当日关注点来自交易信息汇总:9月5日主力资金净流出1210.89万元,显示主力资金持续离场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800000673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2565554197","title":"新诺威:截至2025年8月29日股东总数为15,362户","url":"https://stock-news.laohu8.com/highlight/detail?id=2565554197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565554197?lang=zh_cn&edition=full","pubTime":"2025-09-05 18:39","pubTimestamp":1757068751,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)09月05日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年八月 29日公司的股东总数是多少?谢谢新诺威回复:您好,感谢您对公司的关注,截至2025年8月29日,公司合并普通账户和融资融券信用账户股东数为15,362户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500033258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2564363123","title":"中证全指食品指数报5940.96点,前十大权重包含新诺威等","url":"https://stock-news.laohu8.com/highlight/detail?id=2564363123","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564363123?lang=zh_cn&edition=full","pubTime":"2025-09-03 16:09","pubTimestamp":1756886984,"startTime":"0","endTime":"0","summary":"A股三大指数收盘涨跌不一,中证全指食品指数 报5940.96点。数据统计显示,中证全指食品指数近一个月上涨6.27%,近三个月上涨2.62%,年至今上涨6.31%。从中证全指食品指数持仓样本的行业来看,调味品与食用油占比32.19%、其他食品占比27.66%、乳制品占比17.42%、休闲食品占比12.28%、肉制品占比10.44%。在样本公司有特殊事件发生,导致其行业归属发生变更时,将对中证全指行业指数样本进行相应调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/03160952893906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000985.SH","300765","BK0226"],"gpt_icon":0},{"id":"2564307890","title":"9月1日新诺威涨6.71%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564307890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564307890?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:29","pubTimestamp":1756715393,"startTime":"0","endTime":"0","summary":"证券之星消息,9月1日新诺威涨6.71%,收盘报56.96元,换手率1.28%,成交量15.94万手,成交额8.89亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为156.38亿元,最新净值2.0208,较上一交易日上涨3.42%,近一年上涨43.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100021317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765","159760"],"gpt_icon":0},{"id":"2563012008","title":"8月29日新诺威涨7.30%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2563012008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563012008?lang=zh_cn&edition=full","pubTime":"2025-08-29 16:26","pubTimestamp":1756455965,"startTime":"0","endTime":"0","summary":"证券之星消息,8月29日新诺威涨7.30%,收盘报53.38元,换手率0.89%,成交量11.13万手,成交额5.83亿元。重仓新诺威的前十大公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级4家。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为156.38亿元,最新净值1.9539,较上一交易日下跌0.32%,近一年上涨40.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900029725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0226","300765"],"gpt_icon":0},{"id":"2562112072","title":"8月25日新诺威涨6.69%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562112072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562112072?lang=zh_cn&edition=full","pubTime":"2025-08-25 16:33","pubTimestamp":1756110808,"startTime":"0","endTime":"0","summary":"证券之星消息,8月25日新诺威涨6.69%,收盘报54.25元,换手率0.87%,成交量10.87万手,成交额5.78亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共60家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为156.38亿元,最新净值1.9979,较上一交易日上涨0.85%,近一年上涨41.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500021869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","300765","BK0226"],"gpt_icon":0},{"id":"2561475393","title":"新诺威:截至2025年8月20日股东总数为16,737户","url":"https://stock-news.laohu8.com/highlight/detail?id=2561475393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561475393?lang=zh_cn&edition=full","pubTime":"2025-08-22 18:39","pubTimestamp":1755859147,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)08月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年八月 20日公司的股东总数是多少?谢谢新诺威回复:您好,感谢您对公司的关注,截至2025年8月20日,公司合并普通账户和融资融券信用账户股东数为16,737户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200035268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2561422282","title":"新诺威最新公告:控股子公司SYS6036注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2561422282","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561422282?lang=zh_cn&edition=full","pubTime":"2025-08-22 17:03","pubTimestamp":1755853386,"startTime":"0","endTime":"0","summary":"新诺威(300765.SZ)公告称,公司控股子公司巨石生物近日收到国家药品监督管理局核准签发的关于SYS6036注射液的《药物临床试验批准通知书》,将于近期开展临床试验。SYS6036注射液是一款肿瘤免疫治疗的人源化单克隆抗体药物,按照治疗用生物制品3.3类申报,预计将适用于治疗黑色素瘤、非小细胞肺癌、食管癌、头颈部鳞状细胞癌等多种肿瘤。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082200030513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2561543572","title":"新诺威获融资买入0.21亿元,近三日累计买入0.61亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561543572","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561543572?lang=zh_cn&edition=full","pubTime":"2025-08-21 08:53","pubTimestamp":1755737612,"startTime":"0","endTime":"0","summary":"8月20日,沪深两融数据显示,新诺威获融资买入额0.21亿元,居两市第2213位,当日融资偿还额0.12亿元,净买入886.40万元。最近三个交易日,15日-20日,新诺威分别获融资买入0.12亿元、0.29亿元、0.21亿元。融券方面,当日融券卖出0.37万股,净卖出0.13万股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21085352579725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2560698071","title":"新诺威:度普利尤单抗注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2560698071","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560698071?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:19","pubTimestamp":1755591555,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2560516617","title":"新诺威:控股子公司度普利尤单抗注射液获药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2560516617","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560516617?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:09","pubTimestamp":1755590997,"startTime":"0","endTime":"0","summary":"新诺威公告,控股子公司石药集团巨石生物制药有限公司收到国家药品监督管理局核准签发的关于度普利尤单抗注射液的《药物临床试验批准通知书》,将于近期开展临床试验。度普利尤单抗注射液为靶向IL-4Rα的重组全人源单克隆抗体药物,为达必妥®的生物类似药,适用于治疗成人中重度特应性皮炎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/19160952532807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2560789972","title":"研报掘金丨东吴证券:维持新诺威“买入”评级,功能性食品和原料药业务逐步企稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2560789972","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560789972?lang=zh_cn&edition=full","pubTime":"2025-08-18 15:41","pubTimestamp":1755502915,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159839","601555","BK0028","159646","300765","BK0226","ADC","BK0188","BK0009","BK0183","BK0276","BK0012","BK4231","BK4080"],"gpt_icon":0},{"id":"2559915725","title":"新诺威:截至2025年8月8日股东总数为15,619户","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559915725?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:18","pubTimestamp":1755253110,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)08月15日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,截至2025年八月 8日公司的股东总数是多少?谢谢新诺威回复:您好,感谢您对公司的关注,截至2025年8月8日,公司合并普通账户和融资融券信用账户股东数为15,619户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500036878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2559915894","title":"新诺威最新公告:上半年净亏损274.61万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915894","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559915894?lang=zh_cn&edition=full","pubTime":"2025-08-15 17:51","pubTimestamp":1755251469,"startTime":"0","endTime":"0","summary":"新诺威(300765.SZ)公告称,上半年营业收入10.5亿元,同比增长7.99%;归属于上市公司股东的净亏损274.61万元,同比盈转亏。公司计划不派发现金红利,不送红股,不以公积金转增股本。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500034297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2559724913","title":"新诺威:上半年净亏损274.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559724913","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559724913?lang=zh_cn&edition=full","pubTime":"2025-08-15 17:47","pubTimestamp":1755251266,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0226","300765"],"gpt_icon":0},{"id":"2557514285","title":"原料药上市公司财务总监PK:40岁及以下CFO占比26% 新诺威戴龙为业内最年轻CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2557514285","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557514285?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:13","pubTimestamp":1754622780,"startTime":"0","endTime":"0","summary":"专题:专题|2024年度A股CFO数据报告:美的集团钟铮年薪946万,比亚迪周亚琳896万作为上市公司核心管理层关键成员,财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股CFO数据报告》显示,2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元,平均年薪为81.48万元。其中,目前仍任职的最年轻的上市公司CFO年龄33岁,为新诺威的戴龙。从薪酬分布看,A股原料药公司CFO年薪平均值为66.12万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605507","BK0028","BK0191","BK0226","BK0188","BK0239","300765","600216"],"gpt_icon":0},{"id":"2557835699","title":"大行评级|里昂:中国医疗健康行业流动性及基本面持续改善,偏好领先大型药厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2557835699","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557835699?lang=zh_cn&edition=full","pubTime":"2025-08-05 10:29","pubTimestamp":1754360961,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TNmain","300765","ZBmain","000963","600276","ZFmain","LU0405327148.USD","BND","GOVT","ZNmain","603259","IEF","IE00BPRC5H50.USD","01093","300347","TLT","01276","LU2125910500.SGD","UBmain","LU1997244956.HKD","IEI","UTRE","01099","IE00BGHQDM52.EUR","603233","BK0200","LU1807302812.USD","03692","LU1960683339.HKD","UTHY","LU2242644610.SGD","UFIV","IE00BVYPNQ40.USD","159992","SHY","159760","300015","LU0417516571.SGD","ZTmain","03347","UTWY","IE00B543WZ88.USD","09926","01477","LU1655091616.SGD","USVN","02359","00867","06978","LU0708995583.HKD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758687445781,"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":-0.0181},{"period":"3month","weight":-0.0592},{"period":"6month","weight":0.3614},{"period":"1year","weight":1.2622},{"period":"ytd","weight":0.8786}],"compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":-0.001},{"period":"3month","weight":0.1059},{"period":"6month","weight":0.1328},{"period":"1year","weight":0.3903},{"period":"ytd","weight":0.1402}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"15362人(较上一季度减少8.22%)","perCapita":"81179股","listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","registeredCapital":"140459万元","survey":" 石药创新制药股份有限公司的主营业务是生物制药和功能食品及原料的研发、生产和销售。公司的主要产品是ADC、mRNA疫苗以及抗体类药物、咖啡因、维生素C含片。","listedPrice":24.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新诺威,300765,新诺威股票,新诺威股票老虎,新诺威股票老虎国际,新诺威行情,新诺威股票行情,新诺威股价,新诺威股市,新诺威股票价格,新诺威股票交易,新诺威股票购买,新诺威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}